Search
Powered By HealthLine
Health Tools
 PSA Test
 The Basics of the Prostate
 Prostate Q&A
 Basics of Erectile Dysfunction
 Tips For Men's Sexual Health
Featured Conditions
 Erectile Dysfunction
 Prostate
 Heart
 Diet & Exercise
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Drug Resistant TB Declines but Still a Threat

Ivanhoe Newswire


Related Encyclopedia
 border=
Amenorrhea
Amniocentesis
Amniocentesis and CVS
Ankylosing Spondylitis
More...

Related Healthscout Videos
 border=
Baby Steps: Fertility Findings
Tumor Detecting App: Medicine's Next Big Thing?
Powerful Combo Reducing Lymphedema
Fighting Breast Cancer on Your Lunch Break
More...

Related Animations
 border=
Breast Reduction
Breast Self-Exam Video
Erectile Dysfunction
Facelift
More...

Related Drug Information
 border=
Actonel
Cialis
Detrol LA
Diflucan
More...

Related News Articles
 border=
Prenatal Antipsychotic Drugs Linked to Motor Delays: Study
Coffee Drinking in Pregnancy Won't Lead to Sleepless Baby: Study
1 in 5 Pharmacies Hinders Teens' Access to 'Morning-After' Pill: Study
'Freezing' Secondary Breast Cancer Tumors Shows Promise
More...

(Ivanhoe Newswire) -- The number of extensively drug-resistant tuberculosis (XDR-TB) cases in the United States has declined in the past 15 years, but new cases of the deadly disease are still being reported. The drop may be related to improved TB and HIV/AIDS control, researchers say.

Tuberculosis is the leading cause of infectious deaths of adults worldwide. Recently, drug-resistant strains of the disease have increased that threat, contributing to 289,000 new cases in 2006. Treating multidrug-resistant TB (MDR-TB) is more than 100 times more expensive than standard TB treatment and requires more intensive care.

Text Continues Below



In 2005, a new category of TB was defined -- XDR-TB -- because of its even greater resistance to drugs.The resistance was especially prevalent in areas throughout the world with a large amount of individuals infected with HIV.

Researchers say from 1993 to 2007, 83 cases of XDR-TB were reported across the country. The number of cases dropped from 18 in 1993 to two in 2007. In the first four years of that time frame, 62 percent of XDR-TB cases involved an HIV-infected person; however, from 1998 to 2007, only 14 percent of the cases occurred in such individuals.

Death rates of XDR-TB were also found to be nearly two times greater than among MDR-TB cases and more than six-times greater than among drug-susceptible TB cases. In addition, those with the severe form of TB were more likely to be Hispanic compared with those with the drug-susceptible form.

Preventing the further emergence of drug resistance is paramount and must include not only TB program strengthening to ensure that patients complete their treatment regimen, but also general health system interventions to improve infection control, study authors concluded.

SOURCE: JAMA, 2008;300[18]:2153-2160

Sign up for a free weekly e-mail on Medical Breakthroughs called First to Know by clicking here.

This article was reported by Ivanhoe.com, who offers Medical Alerts by e-mail every day of the week. To subscribe, go to: http://www.ivanhoe.com/newsalert/.




Last updated 11/12/2008

Related Links
 border=
From Healthscout's partner site on erectile dysfunction, ErectileDysfunctionConnection.com
SELF-TEST: Test your ability to achieve an erection
HOME REMEDY: Treat ED with herbs and supplements
DRUGS: Common drugs used to treat impotence





HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2013. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire